Elevance Health (NYSE:ELV) Issues FY 2026 Earnings Guidance

Key Points

• Elevance Health issued FY 2026 EPS guidance of $27.00, slightly below the analyst consensus estimate of $27.16; no revenue guidance was provided.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $440.90. Fifteen analysts rate the stock a Buy, while eight assign a Hold rating.
• The company reported quarterly EPS of $7.45, beating expectations of $6.21, and announced a quarterly dividend of $1.72, equivalent to an annualized $6.88 payout and a 1.7% yield.

Elevance Health (NYSE:ELV - Get Free Report) issued an update on its FY 2026 earnings guidance on Saturday. The company provided earnings per share guidance of 27.000- for the period, compared to the consensus earnings per share estimate of 27.160. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ELV. Guggenheim raised their price target on Elevance Health from $399.00 to $455.00 and gave the stock a "buy" rating in a research report on Thursday, July 16th. Leerink Partners lifted their target price on Elevance Health from $364.00 to $395.00 and gave the stock a "market perform" rating in a report on Friday, July 17th. Bank of America boosted their price objective on Elevance Health from $435.00 to $460.00 and gave the company a "buy" rating in a report on Thursday, June 4th. Royal Bank Of Canada decreased their price objective on shares of Elevance Health from $439.00 to $424.00 and set a "sector perform" rating for the company in a research report on Thursday, July 16th. Finally, Sanford C. Bernstein set a $488.00 price target on shares of Elevance Health in a research note on Thursday, July 16th. Fifteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. According to MarketBeat, Elevance Health has a consensus rating of "Moderate Buy" and a consensus price target of $440.90.

Elevance Health Stock Performance

Shares of ELV opened at $410.71 on Friday. The company's 50 day simple moving average is $397.09 and its 200-day simple moving average is $369.87. Elevance Health has a 12-month low of $274.84 and a 12-month high of $436.24. The firm has a market cap of $89.07 billion, a PE ratio of 18.25, a price-to-earnings-growth ratio of 2.16 and a beta of 0.69. The company has a current ratio of 1.52, a quick ratio of 1.52 and a debt-to-equity ratio of 0.68.

Elevance Health (NYSE:ELV - Get Free Report) last issued its quarterly earnings results on Wednesday, July 15th. The company reported $7.45 earnings per share for the quarter, topping the consensus estimate of $6.21 by $1.24. The firm had revenue of $49.83 billion during the quarter, compared to the consensus estimate of $48.88 billion. Elevance Health had a return on equity of 14.64% and a net margin of 2.47%.The company's revenue for the quarter was up .8% on a year-over-year basis. During the same period last year, the company earned $8.84 earnings per share. As a group, equities analysts predict that Elevance Health will post 27.18 EPS for the current year.

Elevance Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Thursday, September 10th will be issued a $1.72 dividend. This represents a $6.88 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Thursday, September 10th. Elevance Health's payout ratio is presently 30.58%.

Elevance Health Company Profile

Elevance Health, Inc is a health benefits and services company that provides health insurance, care management and related healthcare solutions in the United States. The company serves individuals, employers and government-sponsored programs through a portfolio that includes commercial health plans, Medicare Advantage and other Medicare products, Medicaid plans, and specialty coverage.

Elevance Health operates a portfolio of Blue Cross Blue Shield-affiliated health plans and offers products such as medical, pharmacy, dental and vision benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.